NCT06405477

EFFECTS OF L-ARGININE SUPPLEMENTATION ON THE RECOVERY OF CARDIORESPIRATORY PARAMETERS AFTER SUBMAXIMAL EXERCISE TEST

Name: Clinical Trial NCT06405477
Creator: Universidade Estadual Paulista Júlio de Mesquita Filho
Keywords: Nutrition, Healthy, L-arginine, dietary supplement, clinical trial, Brazil

Universidade Estadual Paulista Júlio de Mesquita Filho·ClinicalTrials.gov·dietary supplementRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Nutrition, Healthy
Drug/Device/Intervention: L-arginine
Study type: Interventional
Intervention type: dietary supplement

Sponsor & location

Primary sponsor: Universidade Estadual Paulista Júlio de Mesquita Filho
Location: Presidente Prudente, Brazil

Timeline & enrollment

Phase: N/A
Start date: Feb 15, 2024
End date: Aug 15, 2024
Enrollment: 35 participants

Primary outcome

Autonomic Nervous System

Summary

L-Arginine is an amino acid capable of stimulating the production of nitric oxide (NO) metabolites. NO is responsible for several important activities of the body, such as: helping to regulate vasodilation, blood flow, mitochondrial respiration, platelet function and increasing growth hormone levels, but the effects on the recovery of cardiorespiratory parameters after exercise testing maximum need to be clarified.

ICD-10 classifications

Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmfulMalnutritionObesitySequelae of malnutrition and other nutritional deficienciesNutritional deficiency, unspecified

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06405477
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06405477 through Pure Global AI's free database. This phase not specified trial is sponsored by Universidade Estadual Paulista Júlio de Mesquita Filho and is currently Recruiting. The study focuses on Nutrition, Healthy. Target enrollment is 35 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.